PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
52.82%
R&D change of 52.82% versus flat Healthcare spending. Walter Schloss would verify adequacy.
-14.04%
G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.04%
Operating expenses change of 9.04% versus flat Healthcare costs. Walter Schloss would verify control.
9.04%
Total costs change of 9.04% versus flat Healthcare costs. Walter Schloss would verify control.
104.89%
Interest expense change of 104.89% versus flat Healthcare costs. Walter Schloss would verify control.
No Data
No Data available this quarter, please select a different quarter.
-9.04%
EBITDA decline while Healthcare median is 0.01%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-9.04%
Operating income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
114.37%
Other expenses change of 114.37% versus flat Healthcare. Walter Schloss would verify control.
48.96%
Income change of 48.96% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
135.99%
Tax expense change of 135.99% versus flat Healthcare. Walter Schloss would verify strategy.
48.96%
Income change of 48.96% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
53.59%
EPS change of 53.59% versus flat Healthcare. Walter Schloss would verify quality.
51.99%
Diluted EPS change of 51.99% versus flat Healthcare. Walter Schloss would verify quality.
10.21%
Share count reduction below 50% of Healthcare median of 0.02%. Jim Chanos would check for issues.
6.42%
Diluted share reduction below 50% of Healthcare median of 0.04%. Jim Chanos would check for issues.